Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current Allergy and Asthma Reports
Published in: Current Allergy and Asthma Reports 2/2012

Open Access 01-04-2012 | Sinusitis (ML Kowalski, Section Editor)

Role of Innate Immunity in the Pathogenesis of Chronic Rhinosinusitis: Progress and New Avenues

Authors: Cornelis M. van Drunen, Jenny M. Mjösberg, Christine L. Segboer, Marjolein E. Cornet, Wytske J. Fokkens

Published in: Current Allergy and Asthma Reports | Issue 2/2012

Login to get access

Abstract

Chronic rhinosinusitis is a heterogeneous and multifactorial disease with unknown etiology. Aberrant responses to microorganisms have been suggested to play a role in the pathophysiology of the disease. Research has focused on the presence, detection, response to, and eradication of these potential threats. Main topics seem to center on the contribution of structural cells such as epithelium and fibroblasts, on the consequences of activation of pattern-recognition receptors, and on the role of antimicrobial agents. This research should be viewed not only in the light of a comparison between healthy and diseased individuals, but also in a comparison between patients who do or do not respond to treatment. New players that could play a role in the pathophysiology seem to surface at regular intervals, adding to our understanding (and the complexity) of the disease and opening new avenues that may help fight this incapacitating disease.
Literature
1.
Vroling AB, Fokkens WJ, van Drunen CM. How epithelial cells detect danger: aiding the immune response. Allergy. 2008;63(9):1110–23.PubMedCrossRef
2.
•• Lane AP. The role of innate immunity in the pathogenesis of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2009, 9(3):205–12. This is an excellent overview on the role of innate immunity in CRS prior to 2009.
3.
Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007;20:1–136.PubMed
4.
• Hastan D, Fokkens WJ, Bachert C, et al: Chronic rhinosinusitis in Europe—an underestimated disease. A GA²LEN study. Allergy. 2011, 66(9):1216–23. This article presents the first pan-European data on the epidemiology of CRS.
5.
• Fokkens W, Lund V, Mullol J, et al: EP3OS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Rhinology. 2012, 50(1):1–150. This is the latest update on the pathogenesis and treatment of CRS.
6.
van Drunen CM, Reinartz S, Wigman J, Fokkens WJ. Inflammation in chronic rhinosinusitis and nasal polyposis. Immunol Allergy Clin North Am. 2009;29(4):621–9.PubMedCrossRef
7.
Van Crombruggen K, Zhang N, Gevaert P, Tomassen P, Bachert C. Pathogenesis of chronic rhinosinusitis: inflammation. J Allergy Clin Immunol. 2011;128(4):728–32.PubMedCrossRef
8.
Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol. 2008;122(5):961–8.PubMedCrossRef
9.
Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol. 2009;124(3):478–84.PubMedCrossRef
10.
Fokkens WJ, Ebbens F, van Drunen CM. Fungus: a role in pathophysiology of chronic rhinosinusitis, disease modifier, a treatment target, or no role at all? Immunol Allergy Clin North Am. 2009;29(4):677–88.PubMedCrossRef
11.
Stow NW, Douglas R, Tantilipikorn P, Lacroix JS. Superantigens. Otolaryngol Clin North Am. 2010;43(3):489–502.PubMedCrossRef
12.
Kilty SJ, Desrosiers MY. Are biofilms the answer in the pathophysiology and treatment of chronic rhinosinusitis? Immunol Allergy Clin North Am. 2009;29(4):645–56.PubMedCrossRef
13.
Weschta M, Rimek D, Formanek M, et al. H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004;113(6):1122–8.PubMedCrossRef
14.
Ebbens FA, Scadding GK, Badia L, et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006;118(5):1149–56.PubMedCrossRef
15.
Ebbens FA, Georgalas C, Luiten S, et al. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope. 2009;119(2):401–8.PubMedCrossRef
16.
Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol. 2005;115(1):125–31.PubMedCrossRef
17.
Sacks PL, Harvey RJ, Rimmer J, et al: Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev. 2011, (8).
18.
Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. The Laryngoscope. 2006;116(2):189–93.PubMedCrossRef
19.
Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps. J Allergy Clin Immunol. 2010;125(5):1069–76.PubMedCrossRef
20.
Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial. Allergy. 2011;66(11):1457–68.PubMedCrossRef
21.
Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011;128(5):989–95.PubMedCrossRef
22.
Langier S, Landsberg R, Sade K, Kivity S. Anti-IL-5 immunomodulates the effect of Staphylococcus aureus enterotoxin on T cell response in nasal polyps. Rhinology. 2011;49(5):570–6.PubMed
23.
Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol. 2006;20(2):138–44.PubMed
24.
Tewfik MA, Bossé Y, Hudson TJ, et al. Assessment of Toll-like receptor 2 gene polymorphisms in severe chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2008;37(4):552–8.PubMed
25.
Nonaka M, Ogihara N, Fukumoto A, et al. Toll-like receptor 2, 3, 4, 5 ligands and interleukin-4 synergistically induce TARC production in nasal polyp fibroblasts. Auris Nasus Larynx. 2008;35(4):515–20.PubMedCrossRef
26.
Nonaka M, Ogihara N, Fukumoto A, et al. Nasal polyp fibroblasts produce MIP-3alpha in response to Toll-like receptor ligands and cytokine stimulation. Rhinology. 2010;48(1):41–6.PubMed
27.
Mansson A, Bogefors J, Cervin A, et al. NOD-like receptors in the human upper airways: a potential role in nasal polyposis. Allergy. 2011;66(5):621–8.PubMedCrossRef
28.
Lalaker A, Nkrumah L, Lee WK, et al. Chitin stimulates expression of acidic mammalian chitinase and eotaxin-3 by human sinonasal epithelial cells in vitro. Am J Rhinol Allergy. 2009;23(1):8–14.PubMedCrossRef
29.
Woods CM, Hooper DN, Ooi EH, et al. Human lysozyme has fungicidal activity against nasal fungi. Am J Rhinol Allergy. 2011;25(4):236–40.PubMedCrossRef
30.
Psaltis AJ, Bruhn MA, Ooi EH, et al. Nasal mucosa expression of lactoferrin in patients with chronic rhinosinusitis. Laryngoscope. 2007;117(11):2030–5.PubMedCrossRef
31.
Thormar H, Hilmarsson H. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem Phys Lipids. 2007;150:1–11.PubMedCrossRef
32.
• Lee JT, Jansen M, Yilma AN, et al: Antimicrobial lipids: novel innate defense molecules are elevated in sinus secretions of patients with chronic rhinosinusitis. Am J Rhinol Allergy. 2010, 24(2):99–104. This article describes a new class of innate defense molecules in CRS.
33.
Laudien M, Dressel S, Harder J, Glaser R. Differential expression pattern of antimicrobial peptides in nasal mucosa and secretion. Rhinology. 2011;49(1):107–11.PubMed
34.
Thienhaus ML, Wohlers J, Podschun R, et al. Antimicrobial peptides in nasal secretion and mucosa with respect to Staphylococcus aureus colonization in chronic rhinosinusitis with nasal polyps. Rhinology. 2011;49(5):554–61.PubMed
35.
van Drunen CM, Vroling AB, Rinia AB, Fokkens WJ. Considerations on the application of microarray analysis in rhinology. Rhinology. 2008;46(4):259–66.PubMed
36.
Castano R, Bossé Y, Endam LM, Desrosiers M. Evidence of association of interleukin-1 receptor-like 1 gene polymorphisms with chronic rhinosinusitis. Am J Rhinol Allergy. 2009;23(4):377–84.PubMedCrossRef
37.
Endam LM, Bossé Y, Filali-Mouhim A, et al. Polymorphisms in the interleukin-22 receptor alpha-1 gene are associated with severe chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2009;140(5):741–7.PubMedCrossRef
38.
Cormier C, Bossé Y, Mfuna L, et al. Polymorphisms in the tumour necrosis factor alpha-induced protein 3 (TNFAIP3) gene are associated with chronic rhinosinusitis. J Otolaryngol Head Neck Surg. 2009;38(1):133–41.PubMed
39.
Castano R, Bossé Y, Endam LM, et al. c-MET pathway involvement in chronic rhinosinusitis: a genetic association analysis. Otolaryngol Head Neck Surg. 2010;142(5):665–71.PubMedCrossRef
40.
Mfuna Endam L, Cormier C, Bossé Y, et al. Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: a replication study. Arch Otolaryngol Head Neck Surg. 2010;136(2):187–92.PubMedCrossRef
41.
Kilty SJ, Bossé Y, Cormier C, et al. Polymorphisms in the SERPINA1 (Alpha-1-Antitrypsin) gene are associated with severe chronic rhinosinusitis unresponsive to medical therapy. Am J Rhinol Allergy. 2010;24(1):e4–9.PubMedCrossRef
42.
Fruth K, Best N, Amro M, et al. No evidence for a correlation of glutathione S-transferase polymorphisms and chronic rhinosinusitis. Rhinology. 2011;49(2):180–4.PubMed
43.
Zhao CY, Wang X, Liu M, Jin DJ. Microarray gene analysis of Toll-like receptor signaling elements in chronic rhinosinusitis with nasal polyps. Int Arch Allergy Immunol. 2011;156(3):297–304.PubMedCrossRef
44.
Schlosser RJ, Mulligan RM, Casey SE, et al. Alterations in gene expression of complement components in chronic rhinosinusitis. Am J Rhinol Allergy. 2010;24(1):21–5.PubMedCrossRef
45.
Babeto E, De Freitas Calmon M, et al. Gene expression analysis reveals novel altered genes in nasal polyps. Mol Med Report. 2010;3(3):485–90.PubMed
46.
Payne SC, Han JK, Huyett P, et al. Microarray analysis of distinct gene transcription profiles in non-eosinophilic chronic sinusitis with nasal polyps. Am J Rhinol. 2008;22(6):568–81.PubMedCrossRef
47.
Platt MP, Soler Z, Metson R, Stankovic KM. Pathways analysis of molecular markers in chronic sinusitis with polyps. Otolaryngol Head Neck Surg. 2011;144(5):802–8.PubMedCrossRef
48.
Wu X, Ghimbovschi S, Aujla PK, et al. Expression profiling of inflammatory mediators in pediatric sinus mucosa. Arch Otolaryngol Head Neck Surg. 2009;135(1):65–72.PubMedCrossRef
49.
Lane AP, Truong-Tran QA, Myers A, et al. Serum amyloid A, properdin, complement 3, and Toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol. 2006;20:117–23.PubMed
50.
Varsano S, Kaminsky M, Kaiser M, et al. Generation of complement C3 and expression of cell membrane complement inhibitory proteins by human bronchial epithelium cell line. Thorax. 2000;55:364–9.PubMedCrossRef
51.
Al Badaai Y, DiFalco MR, Tewfik MA, Samaha M. Quantitative proteomics of nasal mucus in chronic sinusitis with nasal polyposis. J Otolaryngol Head Neck Surg. 2009, 38(3):381–9.
52.
Tewfik MA, Latterich M, DiFalco MR, Samaha M. Proteomics of nasal mucus in chronic rhinosinusitis. Am J Rhinol. 2007;21(6):680–5.PubMedCrossRef
53.
Farajzadeh Deroee A, Oweinah J, Naraghi M, et al. Regression of polypoid nasal mucosa after systemic corticosteroid therapy: a proteomics study. Am J Rhinol Allergy. 2009;23(5):480–5.PubMedCrossRef
54.
Benson LM, Mason CJ, Friedman O, et al. Extensive fractionation and identification of proteins within nasal lavage fluids from allergic rhinitis and asthmatic chronic rhinosinusitis patients. J Sep Sci. 2009;32(1):44–56.PubMedCrossRef
55.
Das S, Maeso PA, Becker AM, et al. Proteomics blood testing to distinguish chronic rhinosinusitis subtypes. Laryngoscope. 2008;118(12):2231–4.PubMedCrossRef
56.
Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol. 2011;12(1):21–7.PubMedCrossRef
57.
Sun JC, Lanier LL. NK cell development, homeostasis and function: parallels with CD8 T cells. Nat Rev Immunol. 2011;11(10):645–57.PubMedCrossRef
58.
Kim MY, Kim KS, McConnell F, Lane P. Lymphoid tissue inducer cells: architects of CD4 immune responses in mice and men. Clin Exp Immunol. 2009;157(1):20–6.PubMedCrossRef
59.
Nuocyotes Neill DR, Wong SH, Bellosi A, et al: Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010, 29;464(7293):1367–70.
60.
Moro K, Yamada T, Tanabe M, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463(7280):540–4.PubMedCrossRef
61.
•• Mjösberg JM, Trifari S, Crellin NK, et al: Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011, 12(11):1055–62. This is the first description of a new class of innate immunity cells that could play an important role in the pathogenesis of CRS.
62.
Reh DD, Wang Y, Ramanathan Jr M, Lane AP. Treatment-recalcitrant chronic rhinosinusitis with polyps is associated with altered epithelial cell expression of interleukin-33. Am J Rhinol Allergy. 2010;24(2):105–9.PubMedCrossRef
63.
Ramanathan Jr M, Spannhake EW, Lane AP. Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor. Laryngoscope. 2007;117(10):1839–43.PubMedCrossRef
64.
Lloyd CM. IL-33 family members and asthma—bridging innate and adaptive immune responses. Curr Opin Immunol. 2010;22(6):800–6.PubMedCrossRef
Metadata
Title
Role of Innate Immunity in the Pathogenesis of Chronic Rhinosinusitis: Progress and New Avenues
Authors
Cornelis M. van Drunen
Jenny M. Mjösberg
Christine L. Segboer
Marjolein E. Cornet
Wytske J. Fokkens
Publication date
01-04-2012
Publisher
Current Science Inc.
Published in
Current Allergy and Asthma Reports / Issue 2/2012
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-012-0249-4

Other articles of this Issue 2/2012

Current Allergy and Asthma Reports 2/2012 Go to the issue

RHINITIS (JN BARANIUK AND JJ OPPENHEIMER, SECTION EDITORS)

Phenotyping of Allergic Rhinitis

Sinusitis (ML Kowalski, Section Editor)

Pathogenesis and Management of Nasal Polyposis in Cystic Fibrosis

Sinusitis (ML Kowalski, Section Editor)

Role of Bacterial and Fungal Biofilms in Chronic Rhinosinusitis

Sinusitis (ML Kowalski, Section Editor)

Management of Smell Dysfunction

Sinusitis (ML Kowalski, Section Editor)

Role of Medical Therapy in the Management of Nasal Polyps

Rhinitis (JN Baraniuk and JJ Oppenheimer, Section Editors)

Rise of the Sensors: Nociception and Pruritus